Certbie
Question 1 of 30
A cosmetic manufacturer, adhering to ISO 22716:2007, consistently receives Certificates of Analysis (CoAs) for a key botanical extract from a new supplier. While the initial CoAs indicated compliance with specifications, the last three consecutive batches have shown minor deviations in a specific impurity profile, although still within the acceptable range defined by the manufacturer\'s internal quality control. The manufacturer\'s quality assurance team is concerned about the trend. What is the most appropriate immediate action according to GMP principles for cosmetic products?
Initiate a formal supplier performance review and potentially a re-qualification audit to assess the root cause of the recurring deviations.
Continue accepting the material as it is still within the acceptable range, but increase the frequency of internal testing on subsequent batches.
Immediately cease all purchases from the supplier and seek an alternative source to avoid any potential future risks.
Request the supplier to simply adjust their internal testing methods to align with the manufacturer's specifications for future CoAs.

Preparing for ISO 22716:2007 - Cosmetics - Good Manufacturing Practices (GMP)? Now land the interview.

73% of qualified candidates get rejected because of weak resumes. Build an ATS-optimized, recruiter-ready resume in under 5 minutes - free to start.

Build My Resume Free